Central Oncology Review is powered by Schulman IRB, the industry-leading independent IRB in customer service and technology. Central Oncology Review builds upon Schulman’s decades of central review experience and their sterling reputation to provide unparalleled service and support to organizations working toward a deeper understanding of cancer therapeutics.

REGULATORY KNOWLEDGE. ONCOLOGY EXPERTISE. 

Central Oncology Review is an independent IRB panel specializing in oncology research. We are pioneers in therapeutically specialized central review, providing the robust human subject protections review cancer research institutions expect. Powered by the collaborative, responsive services of the research community’s preferred central IRB, COR offers a flexible engagement that supports a rigorous, high quality research process.

TRANSPARENT
We maintain a transparent review process, offering access to documents and data in real time and the opportunity to discuss issues with a dedicated support specialist. You'll always know the status of your review.
GET STARTED
EXPERIENCED
Our board roster consists of distinguished oncologists and other individuals from leading cancer institutions, with oncology nursing, pharmacy and pathology experience, as well as patient advocates.
COLLABORATIVE
We’re dedicated to partnering with institutions to navigate the latest developments in oncology research and human subject protections. COR acts as an extension of internal research programs, providing expertise and support.

POWERED BY

NAMES YOU KNOW. INSTITUTIONS YOU TRUST.

Central Oncology Review's dedicated oncology board is populated with trusted experts from some of the top health care systems and cancer centers in the nation.

4445 Lake Forest Drive
Suite 300
Cincinnati, OH 45242
513.761.4100 Phone
866.377.3359 Fax

SUBMIT

REQUEST MORE INFORMATION FROM OUR TEAM:

SUBMIT A NEW STUDY FOR REVIEWESTABLISH A WORKING RELATIONSHIP

CONNECT WITH      

GET STARTED
Fix the following errors:
Hide